Skip to content

SUPERNUS PHARMACEUTICALS, INC.: filings

Every SUPERNUS PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-03fiscal Q2 2026531480001356576-26-000037
10-Q2026-05-05fiscal Q1 2026531120001356576-26-000022
10-K2026-03-02fiscal FY 2025581510001356576-26-000011
10-Q2025-11-06fiscal Q3 2025531490001356576-25-000071
10-Q2025-08-05fiscal Q2 2025531440001356576-25-000055
10-Q2025-05-06fiscal Q1 2025531100001356576-25-000033
10-K2025-02-25fiscal FY 2024571480001356576-25-000017
10-Q2024-11-04fiscal Q3 2024551540001356576-24-000067
10-Q2024-08-06fiscal Q2 2024561540001356576-24-000051
10-Q2024-05-08fiscal Q1 2024551160001356576-24-000028
10-Q2023-11-08fiscal Q3 2023561580001356576-23-000072
10-Q2023-08-08fiscal Q2 2023561540001356576-23-000050
10-Q2023-05-09fiscal Q1 2023561160001356576-23-000034
10-K2023-03-09fiscal FY 2022541380001356576-23-000016
10-Q2022-11-09fiscal Q3 2022541540001356576-22-000076
10-Q2022-08-08fiscal Q2 2022541500001356576-22-000057
10-Q2022-05-12fiscal Q1 2022541120001356576-22-000046
10-K2022-04-13fiscal FY 2021521350001356576-22-000025
10-Q2021-11-05fiscal Q3 2021511480001356576-21-000095
10-Q2021-08-06fiscal Q2 2021521460001356576-21-000082
10-Q2021-05-07fiscal Q1 2021531100001356576-21-000045
10-K2021-03-08fiscal FY 2020541390001356576-21-000028
10-Q2020-11-06fiscal Q3 2020541520001356576-20-000076
10-Q2020-08-17fiscal Q2 2020531440001356576-20-000054
10-Q2020-05-15fiscal Q1 2020521080001356576-20-000031
10-K2020-02-28fiscal FY 2019551810001356576-20-000010
10-Q2019-11-08fiscal Q3 2019521410001356576-19-000045
10-Q2019-08-09fiscal Q2 2019521380001356576-19-000025
10-Q2019-05-10fiscal Q1 2019521050001104659-19-028593
10-K2019-03-01fiscal FY 2018541800001047469-19-000828
10-Q2018-11-09fiscal Q3 2018531390001104659-18-067217
10-Q2018-08-09fiscal Q2 2018531400001104659-18-050920
10-Q2018-05-10fiscal Q1 2018521060001104659-18-032082
10-K2018-03-01fiscal FY 2017521670001047469-18-001210
10-Q2017-11-09fiscal Q3 2017501330001104659-17-067057
10-Q2017-08-03fiscal Q2 2017501330001104659-17-049286
10-Q2017-05-09fiscal Q1 201745910001104659-17-031191
10-K2017-03-16fiscal FY 2016471450001047469-17-001684
10-Q/A2017-01-23fiscal Q2 2016451460001104659-17-003392
10-Q2017-01-20fiscal Q3 2016461270001104659-17-003388
10-Q/A2017-01-20fiscal Q1 2016451110001104659-17-003386
10-K/A2017-01-20fiscal FY 2015491520001104659-17-003385
10-Q/A2017-01-20fiscal Q3 2015461420001104659-17-003384
10-Q2016-08-05fiscal Q2 2016451260001104659-16-137137
10-Q2016-05-10fiscal Q1 201645910001104659-16-119351
10-K2016-03-09fiscal FY 2015491510001047469-16-010884
10-Q2015-11-09fiscal Q3 2015461220001104659-15-077295
10-Q2015-08-07fiscal Q2 2015481280001104659-15-057341
10-Q2015-05-06fiscal Q1 201547950001104659-15-034963
10-K2015-03-12fiscal FY 2014471460001047469-15-002068
10-Q2014-11-12fiscal Q3 2014441190001104659-14-079796
10-Q2014-08-12fiscal Q2 2014441170001104659-14-059912
10-Q2014-05-13fiscal Q1 201440800001104659-14-038146
10-K2014-03-21fiscal FY 2013441190001047469-14-002791
10-Q2013-11-13fiscal Q3 2013411060001356576-13-000041
10-Q2013-08-14fiscal Q2 2013401020001356576-13-000016
10-Q2013-05-15fiscal Q1 201340790001104659-13-041980
10-K2013-03-15fiscal FY 2012451220001047469-13-002844
10-Q2012-11-02fiscal Q3 2012391000001104659-12-073746
10-Q2012-08-13fiscal Q2 2012371030001104659-12-057393
10-Q2012-06-08fiscal Q1 201233670001104659-12-042614

Inspect the source

Entity
SUPERNUS PHARMACEUTICALS, INC. / CIK 0001356576
Captured
2026-09-20T07:55:43.346Z
SEC response SHA-256
e4ffe1415c2b501e2c67d7dc14c0bfee891abde97e80adbe5035738fc4156668

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001356576.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))